Kamstrup, Peter
Sivapalan, Pradeesh
Rønn, Christian
Rastoder, Ema
Modin, Daniel
Kristensen, Anna Kjaer
Bendstrup, Elisabeth
Sørensen, Rikke
Biering-Sørensen, Tor
Ulrik, Charlotte Suppli
Vestbo, Jørgen
Jensen, Jens-Ulrik
Funding for this research was provided by:
Royal Library, Copenhagen University Library
Article History
Received: 24 March 2023
Accepted: 8 June 2023
First Online: 27 June 2023
Declarations
:
: The study has been approved by the Danish Data Protection Agency (approval number P-2019-831). In Denmark, use of register data does not require ethical approval or patient consent.
: Outside the submitted work: C.S.U. has received grants from Sanofi, Boehringer Ingelheim, AstraZeneca, and Novartis and speaker fees from Orion Pharma, AstraZeneca, and TEVA and consulting fees from Chiesi, Orion Pharma, AstraZeneca, GSK, and TEVA, and been on advisory boards for Novartis, Sanofi, Glaxo-Smith Kline, Chiesi, AstraZeneca, and Boehringer Ingelheim. E.B. has received speaker fees from Boehringer Ingelheim, Hoffmann la Roche, AstraZeneca, GSK, and Daiichi Sankyo, and support for attending meetings/travel from Boehringer Ingelheim, and Hoffmann la Roche and participation on DSMB or advisory board for Boehringer Ingelheim, AbbVie, and Galapagos. T.B-S. received consulting fees from GSK and Sanofi Pasteur and received speaker payments from Bayer, Sanofi Pasteur, and GSK and support for meetings/travel from AstraZeneca and received equipment for his department from GE. R.S. received support for attending meetings/travel from Abbott. All other authors report no conflicts of interest.